Lupus disease. Clinical aspects and biology
Dudognon, M.
Revue de l'Infirmiere 21(8): 779-783
1971
ISSN/ISBN: 1293-8505 PMID: 5210617 Document Number: 43559
Document emailed within 1 workday
Related Documents
Costallat, L.T.; Coimbra, A.M. 1994: Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset Clinical and Experimental Rheumatology 12(6): 603-607Moradpour, D.; Blum, H.E. 1996: New hepatitis viruses. Molecular biology and clinical aspects Der Internist 37(9): 903-911
Ginzburg, N.B. 1970: Peculiarities of the clinical aspects of systemic lupus erythematosus in males Klinicheskaia Meditsina 48(5): 135-139
Garcia-Torres, R.; Cruz, D.; Orozco, L.; Heidet, L.; Gubler, M.C. 2000: Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. a synthesis Nephrologie 21(1): 9-12
Grebennikov, V.A.; Gavrilenko, V.E. 1984: Clinical aspects of chronic lupus erythematosus in a markedly continental climate Vestnik Dermatologii i Venerologii 5: 20-24
Prichard, B.N. 1990: Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists Zeitschrift für Kardiologie 79(Suppl 3): 99-103
Glimcher, M.J.; Kenzora, J.E. 1979: Nicolas Andry award. The biology of osteonecrosis of the human femoral head and its clinical implications: 1. Tissue biology Clinical orthopaedics and related research 1979(138): 284-309
Bousquet, B.; Charret, J.; Dreux, C.; Gaudeau-Toussaint, M.F.; Gruson, A.; Marcelli, A.; de Mouy, D.; Plaisance, J.J.; Sachs, C.; Trivin, F.; Valdiguié, P.; Zerah, S. 1998: Thoughts and recommendations concerning the accreditation of hospital and private medical biology laboratories. Working Group of the French Society of Clinical Biology Annales de Biologie Clinique 56(4): 504-507
Jahn, G.; Blenk, H. 1983: Demonstration of a tetracycline-resistance factor in a genital Mycoplasma strain. Clinical and molecular biology aspects of Ureaplasma coinfected penicilliń and tetracycline-resistant gonorrhea Fortschritte der Medizin 101(46): 2129-2132
Bogdanović, R.; Nikolić, V.; Ognjanović, M.; Dimitrijević, J.; Marković-Lipkovski, J.; Pasić, S.; Minić, A.; Stajić, N. 2002: Lupus nephritis in children and adolescents: clinical and morphologic aspects and clinico-morphologic correlations Srpski Arhiv Za Celokupno Lekarstvo 130(Suppl 3): 1-5
De Belilovsky, C.; Lessana-Leibowitch, M. 1993: Bowen's disease and bowenoid papulosis: comparative clinical, viral, and disease progression aspects Contraception Fertilite Sexualite 21(3): 231-236
May, B.; Helmstaedt, D. 1975: Liver disease in drug addicts: clinical course-toxicological and clinical pharmacological aspects International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 50-56
Guillet, G.; Gin, H.; Aubertin, J. 1983: Anticytoplasmic antibodies (Ro and La) and connective tissue disease: clinical and biological heterogeneity of systemic lupus La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(8): 513-516
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Petri, M. 1998: The effect of race on incidence and clinical course in systemic lupus erythematosus: the Hopkins Lupus Cohort Journal of the American Medical Women's Association 53(1): 9-12
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
Gheita, T.A.; Abdel Rehim, D.M.; Kenawy, S.A.; Gheita, H.A. 2015: Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage Acta Reumatologica Portuguesa 40(2): 145-149
Parker, M.D. 1973: Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease Journal of Laboratory and Clinical Medicine 82(5): 769-775